Jove
Visualize
Contact Us

Related Experiment Videos

What's New in beta-lactamases?

Patricia A. Bradford1

  • 1Wyeth-Ayerst Research, 401 Middletown Road, Pearl River, NY 10965, USA. bradfop@war,wyeth.com.

Current Infectious Disease Reports
|February 15, 2001
PubMed
Summary

Beta-lactamase enzymes are the primary cause of resistance to beta-lactam antibiotics in gram-negative bacteria. Rising prevalence of various beta-lactamases presents significant therapeutic challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Beta-lactamase enzymes are the principal mechanism of resistance to beta-lactam antibiotics in Gram-negative bacteria.
  • Recent years have seen a concerning increase in the incidence and prevalence of several key beta-lactamase types.

Purpose of the Study:

  • To highlight the growing threat posed by various beta-lactamase enzymes.
  • To underscore the therapeutic challenges associated with antibiotic resistance.

Main Methods:

  • Review of current literature on beta-lactamase prevalence and resistance patterns.
  • Analysis of the impact of different beta-lactamase classes on antibiotic efficacy.

Main Results:

  • Extended-spectrum beta-lactamases (ESBLs), inhibitor-resistant beta-lactamases (IRBLs), AmpC-type enzymes, metallo-carbapenemases (MCRs), and non-metallo-carbapenemases (NMCRs) are increasingly prevalent.
  • These enzymes confer resistance to critical antibiotic classes including oximino-cephalosporins, beta-lactam/beta-lactamase inhibitor combinations, cephamycins, and carbapenems.

Conclusions:

  • The rise of diverse beta-lactamases poses a significant and growing therapeutic challenge for treating Gram-negative bacterial infections.
  • Urgent strategies are needed to combat the spread of these resistance mechanisms and preserve the effectiveness of existing antibiotics.

Related Experiment Videos